Oncaspar European Union - English - EMA (European Medicines Agency)

oncaspar

les laboratoires servier - pegaspargase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents, - oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukaemia (all) in paediatric patients from birth to 18 years, and adult patients.,

Oncaspar European Union - English - EMA (European Medicines Agency)

oncaspar

baxalta innovations gmbh - pegaspargase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents, - oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukaemia (all) in paediatric patients from birth to 18 years, and adult patients.,

ONCASPAR 750 UML Israel - English - Ministry of Health

oncaspar 750 uml

tzamal bio-pharma ltd - pegaspargase - powder for solution for inj/inf - pegaspargase 3750 u/vial - pegaspargase - oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukaemia (all) in paediatric patients from birth to 18 years, and adult patients.

ONCASPAR POWDER FOR SOLUTION FOR INJECTIONINFUSION 750 UML Singapore - English - HSA (Health Sciences Authority)

oncaspar powder for solution for injectioninfusion 750 uml

servier (s) pte ltd - pegaspargase - injection, powder, lyophilized, for solution - pegaspargase 750 u/ml

ONCASPAR LIQUID Canada - English - Health Canada

oncaspar liquid

aventis pharma inc - pegaspargase - liquid - 750unit - pegaspargase 750unit - antineoplastic agents

ONCASPAR SOLUTION Canada - English - Health Canada

oncaspar solution

servier canada inc - pegaspargase - solution - 750unit - pegaspargase 750unit - antineoplastic agents